Case 1: Introduction November is National Bladder Awareness Month, a crucial time to highlight bladder health and the importance of managing incontinence as we age. At etectRx, we believe it is essential to initiate a transformative shift in how...
Read more
Trilogy Health Services Partners with etectRx for Deployment of Novel Intelligent Incontinence Care Solution GAINESVILLE, Fla. (September 12, 2024) – etectRx™, Inc. (etectRx™), a privately held health sensor platform company, today...
Read more
Partnership Marks First Industry Use of Novel Disposable eBrief GAINESVILLE, Fla. (November 13, 2023) – etectRx™, Inc. (etectRx™), a privately held silicon-enabled digital health sensor platform company, today announced a...
Read moreetectRx™, Inc. (etectRx™), the standard in FDA-cleared digital medication adherence, today announced that its digital pill, the ID-Cap System has surpassed 10,000 ingestions, a significant milestone for the company with a reputation...
Read moreIn 2022 the Centers for Medicare and Medicaid Services (CMS) expanded its digital health coverage and began reimbursing providers for remote therapy monitoring (RTM). RTM differs from existing Remote Patient Monitoring (RPM) in that it monitors...
Read moreCOVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from etectRx resumed in July of 2020. etectRx sought to understand if...
Read moreTuberculosis (TB) represents a significant public health threat in India. Adherence to antitubercular therapy (ATT) is the key to reducing the burden of this infectious disease. Suboptimal adherence to ATT and lack of demonstrated feasibility of...
Read moreThe partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor Liege, Belgium (APRIL 28th, 2022) – Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in...
Read moreOur ID-Cap™ System was recently utilized in a clinical study in Boston, MA resulting in a research report drafted by Principal Investigator Dr. Peter Chai that surrounded the use of a digital pill system (DPS) for real-time, objective...
Read moreThose who design and run clinical trials often worry about medication adherence among trial participants. Nonadherence is a significant concern in all types of clinical trials, from earlier stages of drug development (including pharmacokinetic...
Read moreCompany Founder Takes the Helm of etectRx, a Digital Health Company GAINESVILLE, Fla. (August 2, 2021) – etectRx™, Inc. (etectRx™), a privately held digital health company, today announced the appointment of Eric Buffkin as its next...
Read moreCancer is often highly treatable due to new therapies, especially oral agents, that have improved outcomes and survival rates, and allow patients to be treated outside the hospital setting. Yet many patients fail to take their medication...
Read more